Gene Query: RABGGTB

Dataset Description Geneva Score
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 134.93
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 80.55
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 80.55
Argonaute proteins couple chromatin silencing to alternative splicing 76.54
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 76.54
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 45.61
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 37.52
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 34.4
Next generation sequencing of small RNAs isolated from exosomes in human semen 34.39
Efficient and quantitative high-throughput tRNA sequencing 34.01
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 32.03
Identification of transcription start sites for human A549 cell line using ReCappable-seq 31.38
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 28.73
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 28.73
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 26.19
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 25.03
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 24.5
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 23.95
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 23.76
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 23.39
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 23.39
Transcriptome analysis of U87 cells upon LINC00152 knockdown 23.3
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 23.0
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 22.98
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 22.94
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 22.94
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 22.84
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 22.81
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 22.81
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 22.55
Co-transcriptional loading of RNA export factors shapes the human transcriptome 22.0
RNAseq of HEK293 cells after Chtop knockdown 22.0
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 21.86
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 21.16
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 20.44
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 20.37
Functional role of SLIT2 and ROBO1 in trophoblasts 20.08
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 20.07
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 19.83
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 19.53
Single-nucleotide-resolution mapping of HBV promoters using CAGE 19.08
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 19.01
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 18.79
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 18.7
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 18.38
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 18.36
ETV7 and interferon response 18.36
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 18.02
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 17.67
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 17.12
Human cell line and subcutaneous tumor 17.08
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 17.04
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 17.03
Differetially expressed genes after hTR overexpression in U2OS cells 16.96
Identifying the molecular mode of action of itraconazole in colorectal cancer 16.94
3’ Uridylation Expands miRNA Target Repertoire 16.82
Alteration of the microRNA network during the progression of Alzheimer’s disease 16.73
Ribosomal footprinting of MDA-Parental and MDA-LM2 16.54
Transcriptional profiling of LS1034 cells treated with tepoxalin 16.54
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 16.52
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 16.43
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 16.19
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 15.94
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 15.94
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 15.77
Genome wide expression change by RNF168 knocking down in NEC cells 15.75
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 15.51
Ribosomal footprinting of CN34-Parental and CN34-LM1a 15.44
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 15.4
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 15.35
Human cells contain natural double-stranded RNAs with potential regulatory capacity 15.33
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 15.2
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 14.98
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 14.84
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 14.82
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 14.66
High-throughput sequencing of PROMPT-enriched samples. 14.64
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 14.42
RNA-seq of young and quiescent MRC-5 human fibroblasts 14.37
Mitochondrial dsRNA triggers antiviral signalling in humans 14.32
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 14.13
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 14.0
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 13.87
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 13.82
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 13.8
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 13.8
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 13.72
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 13.72
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 13.66
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 13.48
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 13.4
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 13.26
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 13.26
TCF7L1 knockdown in pancreatic cancer 13.13
Effect of PRDM11 depletion in U2932 cells 12.91
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 12.78
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 12.78
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 12.77
K562 polyA RNA-Seq 12.73
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 12.69
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 12.63
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 12.6
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 12.6
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 12.56
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 12.52
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 12.51
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 12.51
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 12.28
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 12.28
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 12.24
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 12.18
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 12.04
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 12.03
HEXIM1 is induced by DHODH inhibition to suppress melanoma 12.03
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 12.03
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 12.02
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 12.02
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 12.02
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 11.97
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 11.97
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 11.96
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 11.9
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 11.83
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 11.73
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 11.73
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 11.72
Reassessment of Exosome Composition 11.69
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 11.66
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 11.66
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 11.6
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 11.58
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 11.58
Nucleoporin-mediated regulation of cell identity genes 11.54
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 11.47
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 11.47
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 11.41
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 11.39
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 11.38
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 11.38
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 11.37
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 11.32
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 11.32
Transcriptome analysis of H9 hESC derived cerebral organoids 11.26
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 11.24
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 11.09
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 11.08
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 11.06
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 11.03
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 11.03
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 11.03
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 11.01
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 10.95
Tracking distinct RNA populations using efficient and reversible covalent chemistry 10.92
Exploring the RNA landscape of endothelial exosomes 10.78
hTERT promotes cell adhesion and migration independent of telomerase activity 10.78
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 10.77
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 10.77
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 10.75
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 10.73
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 10.66
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 10.51
Short and Long RNA sequencing of human mature erythrocytes 10.49
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 10.4
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 10.38
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 10.35
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 10.3
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 10.27
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 10.26
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 10.19
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 10.19
Developmental stage specific chromosome architecture in human erythroid cells 10.11
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 10.11
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 10.05
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 10.04
HEK293 Heat-shock experiment 10.04
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 10.02
SRSF1 role in cellular gene expression and splicing 10.01
Co-regulation of splicing by Rbfox1 and hnRNP M 9.95
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 9.95
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 9.89
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 9.8
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 9.79
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 9.78
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 9.77
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 9.76
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 9.73
MYC dependent mRNA translation shapes gene expression and cell biology 9.7
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 9.68
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 9.68
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 9.63
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 9.57
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 9.57
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 9.54
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 9.54
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 9.53
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 9.52
Gene expression profile of human iPSC-derived nephron progenitor cells 9.47
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 9.45
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 9.45
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 9.43
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 9.43
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 9.42
Gene expression changes in human melanoma cell lines compared to primary melanocytes 9.35
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 9.33
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 9.27
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 9.25
Genes significantly down or Up-regulated upon RNF219 knockdown 9.24
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 9.23
scRNASeq analysis of cycling cardiomyocytes 9.21
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 9.14
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 9.09
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 9.05
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 8.99
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 8.9
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 8.9
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 8.9
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 8.9
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 8.84
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 8.84
Seletive inhibition of CDK9 in DLBCL cell lines 8.82
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 8.81
Effect of drugs on transcriptomic profiles 8.8
SLAM-seq for K562 endogenous mRNA decay 8.79
Determining mRNA half-lives on a transcriptome-wide scale 8.72
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 8.71
High level DNA repair gene expression in human ES cells 8.69
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 8.66
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 8.65
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 8.65
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 8.64
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 8.59
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 8.59
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 8.58
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 8.58
4sU-seq of HFF exposed to salt and heat stress 8.56
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 8.52
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 8.42
RNA-seq of RKO cells with cTAZ KO or putback 8.39
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 8.37
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 8.37
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 8.35
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 8.33
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 8.33
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 8.29
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 8.25
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 8.22
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 8.2
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 8.18
Role of XRN2 ribonucleolytic activity in RNA metabolism 8.14
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 8.1
Human HAP1 cells before and after nutrient deprivation 8.1
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 8.09
Biological effect of chronic mistranslation in mammalian cells 8.06
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 8.0
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 7.91
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 7.88
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 7.88
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 7.88
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 7.86
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 7.86
RNA-Seq of PRMT1 overexpression ECA109 cells 7.84
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 7.83
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 7.79
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 7.75
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 7.75
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 7.68
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 7.64
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 7.6
HBEC-shp53-PCHD7 7.58
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 7.57
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 7.54
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 7.53
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 7.47
Transcriptome analysis upon C6orf203 silencing 7.45
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 7.45
Electronic cigarettes 7.45
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 7.44
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 7.41
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 7.41
Profiling of escape kinetics of viruses subjected to RNAi 7.26
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 7.21
An siRNA screen identifies CHD4 as a target for epigenetic therapy 7.18
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 7.13
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 7.11
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 7.09
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 7.08
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 7.06
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 7.06
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 6.99
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 6.98
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 6.96
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 6.94
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 6.82
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 6.79
BET bromodomain inhibition 6.76
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 6.76
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 6.7
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 6.69
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 6.64
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 6.64
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 6.64
Recovery and analysis of nascent RNA 6.64
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 6.64
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 6.6
RNA sequencing of primary human platelets and in vitro cell lines 6.56
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 6.55
Human embryonic stem cells in E8 and AKIT culture medium 6.55
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 6.46
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 6.45
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 6.45
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 6.43
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 6.37
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 6.32
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 6.31
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 6.31
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 6.31
Global response to chemotherapy-induced apoptosis 6.25
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 6.21
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 6.19
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 6.14
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 6.1
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 6.1
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 6.07
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 6.07
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 6.01
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 5.99
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 5.97
RNA-Seq in neutrophils from Antiphospholipid Syndrome 5.97
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 5.85
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 5.83
Transcriptomic analysis of the HOTAIR-regulated genes 5.83
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 5.8
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 5.8
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 5.79
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 5.76
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 5.76
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 5.73
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 5.72
Role of microRNAs in the interaction between Salmonella and the host cell 5.69
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 5.59
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 5.57
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 5.56
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 5.42
RNA polymerase in pre-B-ALL cell lines 5.36
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 5.35
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 5.28
Expression charcaterization of an internal protocol developed to differentiate RPE cells 5.09
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 4.95
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 4.93
4sUDRB-seq: measuring transcription elongation and initiation genomewide 4.92
Solid phase chemistry to covalently and reversibly capture thiolated RNA 4.9
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 4.89
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 4.88
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 4.86
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 4.84
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.76
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 4.73
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 4.73
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 4.65
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 4.65
p53 activity results in DNA replication fork processivity 4.63
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 4.62
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 4.62
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 4.55
Exploring ILF2 regulatory genes by next-generation sequencing 4.38
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 4.38
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 4.38
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 4.33
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 4.32
Gene expression analysis in response to hypoxic pathway inhibition 4.21
quanTIseq: quantifying immune contexture of human tumors 4.18
CDK4/6 inhibitor resistance in prostate cancer 4.05
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 3.93
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 3.86
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 3.85
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 3.85
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 3.84
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 3.82
Primary Human B-cell Temporal Response to CD40L Stimulation 3.75
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 3.71
EWS-Fli and LNC regulated genes in comparison to GFP samples 3.7
RNA sequencing of human mammary epithelial cells 3.63
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 3.6
Identification of renal resident macrophages across species [C1] 3.54
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 3.48
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 3.46
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 3.46
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 3.46
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 3.33
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 3.33
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 3.28
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 3.2
RNA transcriptome analysis during HSV-1 infection 3.19
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 3.17
Microprocessor mediates transcription termination in long noncoding microRNA genes 3.16
Real-time observation of light-controlled transcription in living cells 3.14
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 3.11
Modeling Human Cancer-induced Cachexia (Human) 3.04
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 2.97
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 2.97
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 2.91
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 2.9
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.78
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 2.75
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 2.72
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 2.65
Regulatory network controlling tumor-promoting inflammation in human cancers 2.65
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.65
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.64
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 2.62
A20 regulates canonical wnt-signaling through an interaction with RIPK4 2.59
Modulation of nonsense-mediated decay by rapamycin 2.51
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 2.47
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 2.46
RNA sequencing of mechanically strained NHEKs and control NHEKs 2.39
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 2.3
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 2.26
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 2.25
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 2.25
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 2.19
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.13
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 2.06
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 2.06
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 2.03
Transcriptome analysis of peripheral blood monocytes 2.01
SF3B1 Degron knockdown RNA-seq 2.01
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.98
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.98
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.98
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.87
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 1.83
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.79
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 1.76
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.74
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.74
6mer seed toxicity in viral microRNAs 1.57
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.52
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.48
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.48
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.45
RNA expression profiles comparing primary and omental ovarian carcinoma samples 1.4
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 1.31
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 1.25
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.23
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.2
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 1.14
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 1.13
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 1.05
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.03
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.03
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.98
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.95
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.92
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.92
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.9
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.85
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.84
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.77
Finding missing proteins from epigenetically manipulated human cells 0.76
Aging-associated patterns in the expression of human endogenous retroviruses 0.74
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.72
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 0.7
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 0.7
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.68
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.67
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.66
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 0.66
Function and hormonal regulation of GATA3 in human first trimester placentation 0.63
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.52
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.48
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.48
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.46
Differences in miRNA Detection Levels are Technology and Sequence Dependent 0.42
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 0.42
Enhancer activation during EGF response 0.42
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.37
The contribution of Alu exons to the human proteome 0.37
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 0.35
RNA-seq of primary patient AML samples 0.31
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.31
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 0.3
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.29
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.29
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.27
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.17
A code of mono-phosphorylation modulates the function of RB. 0.15
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 0.11
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 0.1
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.09
Small-molecule targeting of brachyury transcription factor addiction in chordoma 0.07
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.06
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.06
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.05
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.05
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.05
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.04
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 0.01
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation